Excellent culture of caring for employees and patients. Leadership truly encourages a good work life balance. Great medical and dental benefits. Generous vacation time.
Is BMY a good company?
BMY Stock Remains a Strong Fundamental Choice
Bristol Myers Squibb has a profit margin of over 14%, which is better than 86% of the companies in its sector. Additionally, the company’s return on assets is 6.59%, better than 91% of the industry. The company continues to post a double-digit free cash flow (FCF) yield.
Is Bristol Myers profitable?
The company said profit in the quarter rose to $4.2 billion, or $1.93 a share, excluding certain items. That compares with $3.7 billion, or $1.63 per share, a year earlier. Analysts had projected earnings per share of $1.80.
What is it like to work for Bristol Myers Squibb?
Great company with career opportunities.
I enjoy working at BMS. The benefits are generous with one year end shutdown and nice bonuses. Good worklife balance with ability to work from home 50% but it depends on what department you are in.
How many employees does Bristol Myers have?
32,200
Bristol Myers Squibb
| A Bristol Myers Squibb R&D facility in Lawrence, New Jersey | |
|---|---|
| Total assets | US$109.31 billion (2021) |
| Total equity | US$35.95 billion (2021) |
| Number of employees | 32,200 (2021) |
| Website | bms.com |
Is Bristol Myers a buy or sell?
Is Bristol Myers Squibb Co Stock a good buy in 2022, according to Wall Street analysts? The consensus among 11 Wall Street analysts covering (NYSE: BMY) stock is to Buy BMY stock.
What is Bristol Myers known for?
The company is known for biological and pharmaceutical research, producing the antipsychotic Abilify (which it helps market) and its blood thinners Plavix and Eliquis, as well as cancer drug Opdivo.
Is Bristol Myers a good dividend stock?
Bristol Myers pays a dividend of $0.54 per quarter, which works out at $2.16 per annum and yields ~3%, so we can conclude that the company has been delivering for investors across the past 12 months, although it should be added that the company’s stock price was stagnant for the five years before the start of 2022.
Is Bristol a good investment?
Rental Yields
Paired with the average rental yield of property in Bristol is 4.5% per annum (which is above the national average of 3.6%) there is a strong case to invest in property in Bristol.
Is BMS a Fortune 100 company?
Bristol-Myers Squibb | 2022 Fortune 500 | Fortune.
Is it hard to get a job at Bristol Myers Squibb?
Yes, it is hard to get a job at Bristol-Myers Squibb.
Bristol-Myers Squibb is known to have an intense hiring process that typically consists of several phone interviews, a one-on-one interview with a hiring manager, a panel format interview, and a technical company test.
Does GroupM pay well?
The lowest-paid workers at GroupM make less than $47,000 a year, while the highest-paid workers earn over $135,000. GroupM employees in different jobs earn different salaries. In corporate management jobs, employees earn an average salary of $131,650.
What is the dress code at Bristol Myers Squibb?
The dress code at Bristol-Myers Squibb is business casual, and can also be casual in certain roles. However, roles that have a casual dress code are prohibited from wearing jeans.
Who is the biggest employer in Bristol?
- Amazon. 3.8★ 148K. Reviews. 4.9K. Salaries. 32.6K.
- McDonald’s. 3.5★ 103.2K. Reviews. 10.1K. Salaries.
- Tesco. 3.7★ 21.5K. Reviews. 7.1K. Salaries.
- Deloitte. 4.0★ 88K. Reviews. 7.4K. Salaries.
- PwC. 4.0★ 64.6K. Reviews. 6.3K. Salaries.
- EY. 3.9★ 63.5K. Reviews. 4.3K. Salaries.
- NHS. 3.8★ 9.5K. Reviews. 5.1K. Salaries.
- KPMG. 3.8★ 49.9K. Reviews. 3.6K. Salaries.
Is Bristol Myers part of Pfizer?
About the Bristol-Myers Squibb/Pfizer Collaboration
This global alliance combines Bristol-Myers Squibb’s long-standing strengths in cardiovascular drug development and commercialization with Pfizer’s global scale and expertise in this field.
What drugs does Bristol Myers make?
Our medicines
- ABECMA® (idecabtagene vicleucel)
- ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)
- AZACTAM® (aztreonam for injection, USP)
- BREYANZI® (lisocabtagene maraleucel)
- BARACLUDE® (entecavir)
- CAMZYOSTM (mavacamten)
- DROXIA® (hydroxyurea)
- ELIQUIS® (apixaban)
Why did BMY stock go down?
Bristol Myers Squibb stock (NYSE: BMY) was down 6% in yesterday’s trade, while it’s down around 10% in a month. The recent fall can be attributed to the AXIOMATIC MATIC +8.2% -SSP study of Milvexian, which failed to achieve the primary endpoint.
Is BMY overvalued?
The market is currently overvaluing BMY in relation to its projected growth due to the PEG ratio being above the fair market value of 1. BMY’s PEG comes from its forward price to earnings ratio being divided by its growth rate.
When did Bristol Myers stock split?
Stock Split History
| Split Date | Rate |
|---|---|
| April 28, 1977 | 2 for 1 |
| April 28, 1983 | 2 for 1 |
| June 9, 1987 (Issue Date) May 12, 1987 (Record Date) | 2 for 1 |
| February 28, 1997 (Issue Date) February 7, 1997 (Record Date) | 2 for 1 |
How does Bristol Myers make money?
Key Points. Bristol-Myers has multiple top-selling drugs in its portfolio that generate billions in revenue. The company is a money-making machine that could bring in $50 billion in free cash over the next few years. Its low valuation and high dividend yield make it an all-around safe stock to just buy and hold.
How many drugs does Bristol Myers have?
Drugs Associated with Bristol-Myers Squibb Company
Bristol-Myers Squibb Company manufactures, markets and/or distributes more than 36 drugs in the United States. Medications listed here may also be marketed under different names in different countries.